Group One Trading
EWTX icon

Group One Trading’s Edgewise Therapeutics EWTX Stock Holding History

Group One Trading’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$709K Sell
22,500
-16,500
-42% -$476K ﹤0.01% 3017
2025
Q4 		$968K Buy
39,000
+31,000
+388% +$622K ﹤0.01% 2923
2025
Q3 		$130K Buy
8,000
+4,300
+116% +$61K ﹤0.01% 5100
2025
Q2 		$48.5K Sell
3,700
-3,200
-46% -$46.1K ﹤0.01% 5599
2025
Q1 		$152K Sell
6,900
-100
-1% -$2.62K ﹤0.01% 4243
2024
Q4 		$187K Sell
7,000
-25,400
-78% -$809K ﹤0.01% 3984
2024
Q3 		$865K Buy
32,400
+25,000
+338% +$497K ﹤0.01% 2424
2024
Q2 		$133K Sell
7,400
-100
-1% -$1.74K ﹤0.01% 3724
2024
Q1 		$137K Sell
7,500
-3,700
-33% -$58.8K ﹤0.01% 3873
2023
Q4 		$123K Buy
+11,200
New +$78.6K ﹤0.01% 4284

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Group One Trading's EWTX Position: Q2 2025 in Review

Group One Trading sold out of Edgewise Therapeutics (EWTX) in Q2 2025, closing a stake of 12,631 shares — an estimated $182K sold.

Group One Trading first reported a position in EWTX in Q2 2023 and held it in 3 quarters. The position peaked at $278K in Q1 2025. 178 funds tracked by Wall St. Rank hold EWTX as of Q2 2025.

  • Group One Trading reported no remaining Edgewise Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 12,631 Edgewise Therapeutics shares in Q2 2025, an estimated $182K.
  • Group One Trading first reported a position in Edgewise Therapeutics in Q2 2023 and held it in 3 quarters.
  • Group One Trading's Edgewise Therapeutics position peaked at $278K in Q1 2025.
  • 178 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.